首页> 外国专利> DETERMINATION OF THE DEGREE OF DISSOCIATION OF AN A-I APOPROTEIN AND METHOD FOR PREDICTING THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF HIGH-DENSITY LIPOPROTEINS OF HUMAN BLOOD PLASMA CONTROLLING THE MAIN ROUTE OF RELEASE OF CHOLESTEROL FROM MACROPHAGES

DETERMINATION OF THE DEGREE OF DISSOCIATION OF AN A-I APOPROTEIN AND METHOD FOR PREDICTING THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF HIGH-DENSITY LIPOPROTEINS OF HUMAN BLOOD PLASMA CONTROLLING THE MAIN ROUTE OF RELEASE OF CHOLESTEROL FROM MACROPHAGES

机译:测定A-i籽蛋白的解离和预测人血浆高密度脂蛋白的结构和功能性能控制从巨噬细胞释放胆固醇的主要途径

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of lipoproteomics, metabolomics, cellular biology, atherogenesis, structural biology, molecular cardiology. The invention pertains to a method for determining the degree of dissociation of an A-I apoprotein. The method includes collecting blood in male patients without atherosclerosis and performing denaturation of high-density lipoprotein (HDL) preparations obtained by precipitation of apoB-containing lipoproteins with polyethylene glycol by urea; measuring the dissociation of apoA-I occurring during denaturation of the HDL by the accumulation of preβ-apoA-I in separation of the HDL by electrophoresis in an agarose gel followed by immunodetection of an apoprotein in a replica of the gel; the effect of induction of dissociation of apoA-I by urea on the functional properties of the HDL is identified by measuring the АВСА1-mediated efflux of a fluorescent cholesterol analogue from the mouse macrophage line RAW 264.7 on the HDL of patients as a cholesterol acceptor. The degree of dissociation of apoA-I (D) is then calculated as the gain in the proportion of preβ-apoA-I relative to the native HDL by the formula.;EFFECT: invention ensures identification of new structural and functional properties of high-density lipoprotein particles of human blood plasma determining the atheroprotective properties thereof.;1 cl, 3 tbl, 4 dwg
机译:田间:医学。物质:发明涉及脂蛋白,代谢组科,细胞生物学,血动血,结构生物学,分子心脏病领域。本发明涉及用于确定A-I opoProtein的解离程度的方法。该方法包括在没有动脉粥样硬化的情况下收集血液患者,并进行高密度脂蛋白(HDL)制剂的变性,通过尿素与聚乙二醇沉淀含孔脂蛋白的沉淀;通过在琼脂糖凝胶中通过电泳在HDL中分离HDL在HDL的变性期间测量APOA-1的解离,然后在凝胶的复制品中免疫诱导蛋白的免疫缩放;通过测量来自小鼠巨噬细胞系的荧光胆固醇类似物的荧光胆固醇型类似物质的α1-介导的264.7在患者的HDL作为胆固醇受体的HDL中,诱导尿素对HDL的功能性质的诱导对HDL的功能性质的影响。然后将ApoA-1(d)的解离程度计算为Preβ-apoa-i的比例通过公式的预热。;效果:发明确保鉴定鉴定高的新结构和功能性质密度脂蛋白人血浆颗粒确定其动脉保护性能。; 1 cl,3 tbl,4 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号